Solid Free-Form Fabrication of Tissue-Engineering Scaffolds with a Poly(lactic-co-glycolic acid) Grafted Hyaluronic Acid Conjugate Encapsulating an Intact Bone Morphogenetic Protein-2/Poly(ethylene glycol) Complex

Despite wide applications of bone morphogenetic protein–2 (BMP‐2), there are few methods to incorporate BPM‐2 within polymeric scaffolds while maintaining biological activity. Solid free‐form fabrication (SFF) of tissue‐engineering scaffold is successfully carried out with poly(lactic‐co‐glycolic ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced functional materials 2011-08, Vol.21 (15), p.2906-2912
Hauptverfasser: Park, Jung Kyu, Shim, Jin-Hyung, Kang, Kyung Shin, Yeom, Junseok, Jung, Ho Sang, Kim, Jong Young, Lee, Keum Hong, Kim, Tae-Ho, Kim, Shin-Yoon, Cho, Dong-Woo, Hahn, Sei Kwang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Despite wide applications of bone morphogenetic protein–2 (BMP‐2), there are few methods to incorporate BPM‐2 within polymeric scaffolds while maintaining biological activity. Solid free‐form fabrication (SFF) of tissue‐engineering scaffold is successfully carried out with poly(lactic‐co‐glycolic acid) grafted hyaluronic acid (HA‐PLGA) encapsulating intact BMP‐2/poly(ethylene glycol) (PEG) complex. HA‐PLGA conjugate is synthesized in dimethyl sulfoxide (DMSO) by the conjugation reaction of adipic acid dihydrazide modified HA (HA‐ADH) and PLGA activated with N,N′‐dicyclohexylcarbodiimide (DCC) and N‐hydroxysuccinimide (NHS). BMP‐2 is complexed with PEG, which is encapsulated within the PLGA domain of the HA‐PLGA conjugate by SFF to prepare tissue‐engineering scaffolds. In vitro release tests confirm the sustained release of intact BMP‐2 from the scaffolds for up to a month. After confirmation of the enhanced osteoblast cell growth, and high gene‐expression levels of alkaline phosphatase (ALP), osteocalcin (OC), and osterix (OSX) in the cells, the HA‐PLGA/PEG/BMP‐2 scaffolds are implanted into calvarial bone defects of Sprague Dawley (SD) rats. Microcomputed tomography (μCT) and histological analyses with Masson's trichrome, and hematoxylin and eosin (H&E) staining reveal effective bone regeneration on the scaffolds of HA‐PLGA/PEG/BMP‐2 blends. Sustained release and bone regeneration: Solid free‐form fabrication of tissue‐ engineering scaffold is successfully carried out with a poly(lactic‐co‐glycolic acid) grafted hyaluronic acid (HA‐PLGA) conjugate encapsulating an intact bone morphogenetic protein–2/poly(ethylene glycol) (BMP‐2/PEG) complex. In vitro release tests confirm the sustained release of intact BMP‐2 from the scaffolds for up to a month. Furthermore, microcomputed tomography and histological analysis reveal effective bone regeneration on the HA‐PLGA/PEG/BMP‐2 scaffolds implanted into calvarial bone defects of Sprague Dawley rats.
ISSN:1616-301X
1616-3028
1616-3028
DOI:10.1002/adfm.201100612